Nimbus Healthcare, in collaboration with Snap Kitchen, has launched Nimbus Meals, a 12-week program that combines GLP-1 medication management with physician-designed, ready-to-heat meals to support adherence, metabolic goals, and sustainable health outcomes. The program integrates clinical oversight with meal plans tailored to each patient’s titration schedule, protein targets, and overall dietary needs, while ensuring seamless HSA/FSA payment options and benefits integration through Prado.

Health Technology Insights: OrthAlign Expands Lantern Hip Platform for Posterior THA

GLP-1 therapies have proven effective for weight management, but appetite changes and rapid routine adjustments often make it difficult for patients to meet nutrition goals consistently. Nimbus Meals addresses this challenge by providing meals designed for protein, fiber, and satiety while controlling calories. The program also offers ongoing guidance to help patients develop healthy habits beyond initial weight loss.

Health Technology Insights: Solventum Wins Diamond HIRC Badge for Top Supply Chain Strength

“GLP-1 therapies have changed the conversation about obesity, but they were never meant to work in isolation,” said Dr. Jobby John, PharmD, founder and CEO of Nimbus Healthcare. “Nimbus Meals enables patients to combine medication management with food that supports their goals: food-as-medicine, backed by medicine.”

Lorena Basteris, Vice President of Culinary and Operations at Snap Kitchen, added, “Our focus has always been on real food made with real ingredients. Nimbus Meals makes it easier for patients to reach and sustain their health goals with meals that are satisfying and flavorful.”

The program follows a protocol mapped to GLP-1 initiation and titration and includes support from Nimbus’ clinical team for movement, resistance training, and behavior change. Nimbus Meals is available via flexible subscriptions for individuals and scalable solutions for employers and partners seeking a coordinated approach to GLP-1 therapy.

For employers and payers, the program offers a bundled pathway including GLP-1 medication access, medically tailored meals, and clinical oversight to improve adherence and health outcomes. Eligible patients may use HSA or FSA funds when prescribed for medical necessity.

The program launched in January 2026 with Nimbus’ GLP-1 patients in Texas and is expanding to additional cities and employer partners. Nimbus is also collaborating with local restaurants to identify GLP-1-friendly options for patients outside the subscription program.

Health Technology Insights: Ferronova Raises $6 Million to Boost Image-Guided Cancer Surgery

To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com